262 related articles for article (PubMed ID: 6547150)
1. Lithocholate glucuronide is a cholestatic agent.
Oelberg DG; Chari MV; Little JM; Adcock EW; Lester R
J Clin Invest; 1984 Jun; 73(6):1507-14. PubMed ID: 6547150
[TBL] [Abstract][Full Text] [Related]
2. Cholestasis induced by lithocholate and its glucuronide: their biliary excretion and metabolism.
Takikawa H; Ohki H; Sano N; Kasama T; Yamanaka M
Biochim Biophys Acta; 1991 Jan; 1081(1):39-44. PubMed ID: 1991154
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physical and biological properties of lithocholyl-lysyl-fluorescein: a fluorescent monohydroxy bile salt analogue with cholestatic properties.
Mills CO; Milkiewicz P; Molloy DP; Baxter DJ; Elias E
Biochim Biophys Acta; 1997 Oct; 1336(3):485-96. PubMed ID: 9367176
[TBL] [Abstract][Full Text] [Related]
4. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
Takikawa H; Minagawa K; Sano N; Yamanaka M
Dig Dis Sci; 1993 Aug; 38(8):1543-8. PubMed ID: 8344113
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of lithocholate-induced intrahepatic cholestasis: role of glucuronidation and hydroxylation of lithocholate.
Vu DD; Tuchweber B; Plaa GL; Yousef IM
Biochim Biophys Acta; 1992 Jun; 1126(1):53-9. PubMed ID: 1606175
[TBL] [Abstract][Full Text] [Related]
6. Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in rats.
Takikawa H; Sano N; Yamazaki R; Yamanaka M
J Hepatol; 1995 Jan; 22(1):88-93. PubMed ID: 7751593
[TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.
Takikawa H; Sano N; Narita T; Uchida Y; Yamanaka M; Horie T; Mikami T; Tagaya O
Hepatology; 1991 Aug; 14(2):352-60. PubMed ID: 1860692
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 24-norlithocholic acid in the rat: formation of hydroxyl- and carboxyl-linked glucuronides and effect on bile flow.
Shattuck KE; Radominska-Pyrek A; Zimniak P; Adcock EW; Lester R; St Pyrek J
Hepatology; 1986; 6(5):869-73. PubMed ID: 3758941
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
Cowen AE; Korman MG; Hofmann AF; Cass OW
Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
[TBL] [Abstract][Full Text] [Related]
10. Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry.
Dionne S; Tuchweber B; Plaa GL; Yousef IM
Biochem Pharmacol; 1994 Sep; 48(6):1187-97. PubMed ID: 7945413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biliary excretion and metabolism of lithocholic acid and its sulfate and glucuronide conjugates in rats.
Takikawa H; Sano N; Ohki H; Yamanaka M
Biochim Biophys Acta; 1989 Aug; 1004(2):147-50. PubMed ID: 2752014
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of lithocholic acid in the rat: formation of lithocholic acid 3-O-glucuronide in vivo.
Little JM; Zimniak P; Shattuck KE; Lester R; Radominska A
J Lipid Res; 1990 Apr; 31(4):615-22. PubMed ID: 2351869
[TBL] [Abstract][Full Text] [Related]
13. Defective biliary secretion of bile acid 3-O-glucuronides in rats with hereditary conjugated hyperbilirubinemia.
Kuipers F; Radominska A; Zimniak P; Little JM; Havinga R; Vonk RJ; Lester R
J Lipid Res; 1989 Dec; 30(12):1835-45. PubMed ID: 2516110
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect and uptake mechanism by isolated rat hepatocytes of lithocholate and its glucuronide and sulfate.
Takikawa H; Tomita J; Takemura T; Yamanaka M
Biochim Biophys Acta; 1991 Jan; 1091(2):173-8. PubMed ID: 1995077
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of lithocholic acid and its conjugates by the bile duct-ligated rat.
Little JM; Zimniak P; Radominska A; Lehman P; Lester R
Hepatology; 1991 Oct; 14(4 Pt 1):690-5. PubMed ID: 1916672
[TBL] [Abstract][Full Text] [Related]
16. Hepatic metabolism of 3 alpha-hydroxy-5 beta-etianic acid (3 alpha-hydroxy-5 beta-androstan-17 beta-carboxylic acid) in the adult rat.
Little JM; St Pyrek J; Lester R
J Clin Invest; 1983 Jan; 71(1):73-80. PubMed ID: 6848561
[TBL] [Abstract][Full Text] [Related]
17. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
[TBL] [Abstract][Full Text] [Related]
18. The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates.
Belli DC; Roy CC; Fournier LA; Tuchweber B; Giguère R; Yousef IM
Liver; 1991 Jun; 11(3):162-9. PubMed ID: 1886461
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
Meyers M; Slikker W; Pascoe G; Vore M
J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and effect of 7-oxo-lithocholic acid 3-sulfate on bile flow and biliary lipid secretion in rats.
Yamashita H; Setchell KD
Hepatology; 1994 Sep; 20(3):663-71. PubMed ID: 8076924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
